Consolidated Statements of Cash Flows (USD $)	12 Months Ended				146 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (665,113)	$ (721,841)	$ (694,910)	$ (931,338)	$ (12,187,984)
ADJUSTMENTS TO RECONCILE NET LOSS TO NET CASH USED IN OPERATING ACTIVITIES
Fair value of options issued in exchange for services	96,032	364	1,524	48,472	2,073,558
Accretion of interest on deferred finance charges	27,149	17,641	2,835		440,000
Accretion of discount on notes payable	17,416	18,633	2,230	247,828	438,279
Salary due to stockholder contributed to capital					15,000
Amortization and depreciation	10,904	13,614	14,161	13,915	516,584
Gain on disposition of assets					(4,722)
Gain on forgiveness of debt	(184,242)				(184,242)
Stock issued in exchange for services	30,000	208,600	47,700		507,260
Financing expenses paid directly from stock proceeds					5,270
Amortization of deferred consulting fees					40,800
(Increase) decrease in assets
Receivables	10,193	(8,739)	2,034	(1,494)
Inventory	(11,451)	(4,662)	4,406	5,296	(35,137)
Prepaid expenses	21,936	(139,696)			(117,760)
Increase in liabilities
Accounts payable and accrued expenses	333,291	246,591	348,986	250,805	1,820,886
Net cash used in operating activities	(313,885)	(369,495)	(271,034)	(366,516)	(6,672,208)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment					(35,749)
Purchase of intangibles					(20,000)
Purchase of patent costs	(3,577)	(2,500)	(1,806)	(5,667)	(197,469)
Proceeds from sale of assets					6,738
Net cash used in investing activities	(3,577)	(2,500)	(1,806)	(5,667)	(246,480)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock	400,000				4,491,447
Proceeds from exercise of stock options	10,000				242,369
Proceeds from issuance of stock options					15,000
Proceeds from exercise of warrants					55,500
Proceeds from issuance of notes		486,500	334,000	373,500	2,589,000
Repayments of notes	(58,500)	(20,000)	(18,000)		(196,500)
Purchase of treasury stock	-17795	-	-	-	-17795
Debt issuance costs		(42,000)	(20,000)		(62,000)
Stock issuance costs	(40,000)				(144,760)
Net cash provided by financing activities	293,705	424,500	296,000	373,500	6,972,261
Net increase (decrease) in cash and cash equivalents	(23,757)	52,505	23,160	1,317	53,573
Cash and cash equivalents - Beginning of period	77,330	24,825	1,665	348
Cash and cash equivalents - End of period	53,573	77,330	24,825	1,665	53,573
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Cash paid during the year for interest		91	894	1,538	32,133
Cash paid during the year for income taxes
Return of shares of common stock related to purchase price adjustment of common stock					(1,000)
Return of shares of common stock related to purchase price adjustment of addiontal paid-in capital					(353,000)
Intangible assets					(354,000)
Issuance of common stock and stock options for acquistion of subsidiary					738,000
Proceeds from common stocks sales applied directly to debt and financing expenses repayment					55,270
Fair value of warrants issued for deferred finance charges					392,376
Fair value of stock issued for conversion of notes payable			312,041		312,041
Fair value of beneficial conversion option				25,000	400,000
Fair value of warrants issued as debt discount	21,175	20,143	15,450		56,768
Issuance of common stock for stock issuance costs	2,100				2,100
Issuance of options as stock issuance cost for treasury stock	$ 5,594				$ 5,594